X

Din webbläsare stödjs inte längre!

Din webbläsare, Internet Explorer, är för gammal och stödjs inte längre av detta verktyg. Vänligen uppdatera din webbläsare till Microsoft Edge, Google Chrome eller Mozilla Firefox.

Open Health economic Method Seminar: How to evaluate new oncology treatments

Due to different regulatory initiatives more oncology products are introduced earlier in the development process. Health economic evaluations based on e.g. one-armed Phase 1 and 2 clinical trials requires further innovation and development of health economic methods. The main issue discussed in this seminar is how to handle ‘uncertainty’ due to lack of long-term data at launch. Especially methods of extrapolation beyond trial as well as interpretations of sensitivity analyses will be discussed.

Invitation and program (pdf)

Registration.